Supporting a Healthy Microbiome and Patient Outcomes with Probiotics

Shannahan F . Therapeutic implications of manipulating and mining the microbiota. J Physiol. 2009; 587(17): 4175–9.

Podolsky SH . Metchnikoff and the microbiome. The Lancet. 2012; 380(9856): 1810–1.

Sanders ME . How do we know when something called “probiotic” is really a probiotic? A guideline for consumers and healthcare professionals. Functional Food Rev. 2009; 1(1): 3–12.

Hoffmann DE , Fraser CM , Palumbo FB Probiotics: finding the right regulatory balance. Science. 2013; 342(6156): 314–5.

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific opinion on the substantiation of health claims related to the substantiation of health claims related to various and reduction of gastro-intestinal discomfort (ID 1030, 2956, 2958, 2961, 2963, 2966, 2970), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 1030, 2956, 2958, 2961, 2963, 2966, 2970), improved lactose digestion (ID 1030, 2956, 2958, 2961, 2963, 2966, 2970), “intestinal flora/digestive health” (ID 4231), defence against vaginal pathogens (ID 2950, 2957, 2967) and increasing IL-10 production and/or enhancing the activity of natural killer cells (ID 2960, 2962, 2971) (further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal. 2012; 10(8):2858.

Dunne C , Murphy L , Flynn S Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and human clinical trials. Antoine van Leeuwenhoek. 1999; 76: 279–92.

Bertazzoni E , Donelli G , Midtvedt T Probiotics and clinical effects: is the number what counts? J Chemotherapy. 2013; 25(4): 193–212.